For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who need more options. For patients with prostate cancer, there are many treatment ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...

I’m sharing this information for educational purposes and not for sympathy,” the pop culture critic said. Pop culture critic ...

The UK National Screening Committee said there were more harms than benefits to using the PSA test for screening all men.

The most common symptoms of prostate cancer are needing to urinate more often and straining to pee. Men may also feel as though their bladder has not fully emptied. These symptoms are common and do ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of international research on androgen deprivation therapy (ADT) for prostate cancer ...

The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic Testing for Patients with Advanced Prostate ...

Among US men with grade group 1 (GG1) prostate cancer, about 1 in 6 had intermediate- or high-risk disease, along with increased rates of adverse pathology and cancer-specific mortality. This finding ...

James Pickens Jr. is emphasizing the importance of routine screenings after being diagnosed with prostate cancer.

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as demonstrated by the PRESTO, EMBARK, and ENZARAD trials. The PRESTO trial ...

The UK National Screening Committee said on Friday there were more harms than benefits to using the PSA test for screening all men.